IL6 and Hepatic fibrosis: In contrast, Ye et al., studying PDLIM1’s impact on hepatic stellate cell activation and liver fibrosis progression, observed reduced levels of inflammatory factors (TNF-α, IL-6, and p65) after PDLIM1 knockdown [52].